Analysis

The Top Antitrust Conduct Cases Of 2019: Midyear Report

Law360 (July 3, 2019, 1:28 PM EDT) -- The world’s dominant chipmaker saw part of its business model deemed illegal, the Federal Trade Commission added a new kind of generic drug patent settlement to the list of banned deals, and the European Commission slapped Google and Mastercard with more than $2 billion in fines. And that was just in the first half of 2019.

Here, Law360 looks at some of the biggest antitrust cases for the first six months of the year and what they mean for the next six months and beyond.

A Test For Qualcomm And Patent Licensing

The FTC has sought to undo the allegedly anti-competitive...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS